The close relationship between cGAS-STING-IRF3 pathway and immunotherapy was also well documented 19, 31, 34, suggesting that MYCi975 could be also used to enhance the sensitivity of HNSCC to immunotherapy in the future. The gene discussed is CGAS; the disease is head and neck squamous cell carcinoma.